Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix (BDSX) posted Short-term Investments of $100000.0 for Q2 2022, little changed quarter-over-quarter from $100000.0 in Q4 2021.

Biodesix (BDSX) Short-term Investments (2021 - 2022) Analysis & Trends

Biodesix (BDSX) has reported Short-term Investments for 2 consecutive years, with $100000.0 the latest figure, recorded in Q2 2022.

  • Short-term Investments for Q2 2022 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2022 was $100000.0 (changed N/A YoY), and the FY2021 annual result was $100000.0, changed N/A from the prior year.
  • Short-term Investments was $100000.0 for Q2 2022 at Biodesix, roughly flat from $100000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $100000.0 in Q4 2021 and troughed at $100000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Biodesix 236.57 Mn 211.00 Mn 21.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 100,000.00
Dec 31, 2021 100,000.00